0001171843-23-000853.txt : 20230209 0001171843-23-000853.hdr.sgml : 20230209 20230209162825 ACCESSION NUMBER: 0001171843-23-000853 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230208 FILED AS OF DATE: 20230209 DATE AS OF CHANGE: 20230209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ferneau Philip CENTRAL INDEX KEY: 0001814202 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39696 FILM NUMBER: 23606630 MAIL ADDRESS: STREET 1: 10 ALLEN STREET CITY: HANOVER STATE: NH ZIP: 03755 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Compass Therapeutics, Inc. CENTRAL INDEX KEY: 0001738021 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-500-8099 MAIL ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Olivia Ventures, Inc. DATE OF NAME CHANGE: 20180419 4 1 ownership.xml X0306 4 2023-02-08 0 0001738021 Compass Therapeutics, Inc. CMPX 0001814202 Ferneau Philip C/O COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601 BOSTON MA 02135 1 0 0 0 Stock Option (Right to Buy) 3.93 2023-02-08 4 A 0 50000 0 A 2033-02-07 Common Stock 50000 50000 D The options vest over 48 substantially equal monthly installments starting March 8, 2023. Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. /s/ Neil Lerner, attorney-in-fact 2023-02-09